“I Don't Buy IPOs”: Veteran Investor Names 3 Profitable Space Stocks to Own Instead of SpaceX

The article argues for waiting on SpaceX post-IPO price discovery due to ~911M insider shares coming eligible and potentially tripling public float, while mega-cap space listings increase near-term supply. On fundamentals, it highlights Northrop Grumman Q2 Space Systems revenue of $2.753B (+4% YoY) with 8.6% segment margin and full-year guidance of ~$11B sales (low-10% margins), Lockheed Martin Q2 Space revenue of $3.496B (+6% YoY) with 2026 Space sales of $13.85B-$14.05B, and L3Harris Space & Mission Systems revenue of ~$3.0B (+7%) with 2026 guidance raised by $200M to $11.7B. Overall tone is “long-term upside, but short-term timing uncertainty,” with no clear market-wide impact but meaningful stock-specific positioning around space IPO dynamics.

Analysis

This is less a space-industry fundamental call than a capital-allocation event: a mega-private listing can siphon growth capital away from the public names with the cleanest space exposure, even if their earnings are improving. The first-order loser is likely the highest-multiple public proxy, while the deeper beneficiary set is the boring-but-profitable incumbents that institutions can actually buy today; that scarcity premium tends to show up in months, not days.

The key second-order effect is that a successful SpaceX float may compress the entire “private-space premium” and force a reset in public comps if investors decide they can get more operating leverage elsewhere. But if the offering is disorderly or delayed, the opposite happens: managers crowd into liquid space-defense names as a de-risked alternative, which favors the highest-quality balance sheets and the most visible backlog. In that scenario, LHX should trade best on relative growth visibility, while NOC is the cleaner value catch-up candidate.

Contrarian view: the market may be overestimating how much a private SpaceX listing changes the public opportunity set in the next 1-3 months. The real catalyst is not the IPO narrative itself but the price discovery around filing, lockup, and first post-listing quarters; until then, the public names can continue to rerate on their own fundamentals. What would falsify the setup is a hot, well-absorbed IPO with minimal aftermarket weakness and no spillover into defense multiples over the following 2-4 weeks.

Key Decisions for Investors

• Start a small tactical long LHX on any 3-5% pullback; best mix of growth visibility and defensible profitability in the space bucket. Use a 6-12 month horizon and cut if revenue guidance is not reaffirmed after the next major launch/contract update.
• Pair trade: long NOC / short LMT into the SpaceX filing-to-pricing window. NOC offers more asymmetric catch-up if investors rotate into profitable space exposure, while LMT already embeds a fuller multiple; cover the short if LMT outperforms NOC by >7% without a new defense catalyst.
• No chase in the first 48 hours after any SpaceX pricing news; wait for one full trading session to see whether public-space names are being used as liquidity hedges. If the names gap and hold, add on weakness rather than momentum.
• If the IPO is priced aggressively and the first 2 sessions trade below issue with heavy volume, consider adding to LHX/NOC as the 'profitable space' trade; downside in that case should be temporary while the public comps get re-valued upward.